- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nephrotoxicity of CT Contrast Agents in Netherlands
Total 7 results
-
Prof. Dr. J. WetzelsTerminatedRadiographic Contrast Agent NephropathyNetherlands
-
University Medical Center GroningenAccare; Hanzehogeschool Groningen; GGZ Friesland; WIJ Groningen; Amaryllis LeeuwardenRecruiting
-
Leiden University Medical CenterHollandPTC; Varian Medical SystemsRecruitingMagnetic Resonance Imaging | Chondrosarcoma | Chordoma | Proton Therapy | Bone Neoplasm of Vertebral Column | PET-CTNetherlands
-
AstraZenecaRTI Health SolutionsCompletedCOVID-19, Vaccine Adverse Events of Special InterestNetherlands, Spain, United Kingdom
-
ThromboGenicsBioInvent International ABCompletedProphylaxis of Venous Thromboembolic EventsAustria, Netherlands, Belgium, Bulgaria, Hungary, Latvia, Poland, Russian Federation, Ukraine
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
BayerCompletedHemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic EventsSpain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal